NCT06241677View on ClinicalTrials.gov

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC

NARecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

December 12, 2028

Study Completion Date

March 31, 2029

Conditions
CVA (Cerebrovascular Accident)
Interventions
DRUG

alteplase or tenecteplase

Either alteplase (0.6 or 0.9mg/kg, maximum dosage 90mg) or tenecteplase (0.25mg/kg, maximum dosage 25mg) will be given

Trial Locations (1)

Unknown

RECRUITING

Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

Pamela Youde Nethersole Eastern Hospital

OTHER

collaborator

Queen Mary Hospital, Hong Kong

OTHER

collaborator

Princess Margaret Hospital, Canada

OTHER

collaborator

Tuen Mun Hospital

OTHER_GOV

collaborator

The Queen Elizabeth Hospital

OTHER

collaborator

United Christian Hospital

OTHER

lead

Chinese University of Hong Kong

OTHER